IPI Speaks with Alberto Negra, Technical Manager at Rotor Print about creating a pharmaceutical blister that can be recycled, but without losing the properties of th...

IPI Speaks with Dr Patrick Larcier, Senior Director, Strategy Product Development Solutions, EU & US, of PharmaLex, on Next-generation Small Molecules Q: Can ...

IPI Speaks with Dr. Victor Diaz, Operations Director at Solitek on a New Concept in Solid StateDevelopment Services for the Pharmaceutical, Agrochemical and Fine Che...

IPI Speaks with Mr Anil Busimi, VP, Strategy & Marketing of Terumo Medical Care Solutions (TMCS)on the Recent Changes in the CDMO Industry and what the Market is...

Christian Schmitz-Moormann, a senior consultant and pharmacovigilance (PV) expert, and partner of Generis, considers the role of this essential master resource in ma...

The global pharmaceutical sector is booming thanks to continued growth in R&D spend in new technologies and therapeutic areas, putting the industry back on a mor...

Antibody drug conjugates (ADCs) are a big deal in oncology. And rightly so: they combine highly specific targeting with a potent cytotoxic payload to deliver tremend...

The early detection of disease poses a substantial challenge in the field of human health, necessitating the development of more accurate biomarkers, enhanced patien...

Sustainable system for the treatment of vaginal diseases, part I – pre-clinical laboratory study A holistic approach, to address the state of the vaginal biofilm usi...

The prevalence of decentralised clinical trials, rising demand for preventive healthcare solutions, a market driven by the need for more and better-quality data and ...